ºÚÁÏÍø

Take part

Take part in research studies and surveys currently taking place in Australia.  

Research advertised below is provided as a service to the diabetes research community. This research is not specifically endorsed by ºÚÁÏÍø.   

If you would like to promote a survey or ask for participants, email [email protected].

---

Kellion Victory Medallists research study

Each year ºÚÁÏÍø presents the Kellion Victory Medal to those who have lived with type 1 or type 2 diabetes for 50 years or more.

As part of our ongoing commitment to invest in research that connects diabetes lived experience with researchers and health professionals, ºÚÁÏÍø has partnered with researchers around the country to investigate what makes our Kellion Victory Medallists so special.

To do this, the research teams need people who have received a Kellion Victory Medal to volunteer to be interviewed and assessed. 

Find out more: Kellion Victory Medallists research study

---

Complementary medicines and nutritional supplementation use in young people with type 1 diabetes

Western Sydney University is undertaking research into how and why young people diagnosed with type 1 diabetes use complementary medicine and nutrient supplementation to manage their condition.

They would like to hear from you if:

• You are 12-25 years old
• Are considered at risk of developing T1D (e.g., family history, autoantibody
• positive) OR have been diagnosed with T1D
• Currently living in Australia

To take part, visit:

For more information about this study, you can contact:

Dr Phoebe Zhou: [email protected]
Dr Catharine Fleming: [email protected]

---

Safeguard Study –
Australasian type 1 diabetes immunotherapy collaborative

The is now looking for people aged 16 – 40 who have recently been diagnosed with type 1 diabetes. This study is testing a new treatment that aims to protect the body’s ability to make insulin.

Participants will receive either the study treatment or a placebo (a treatment with no medicine).

Who can get involved:

• People aged between 16 and 40
• Recently diagnosed with type 1 diabetes (within 100 days)
• Living in Victoria, New South Wales or New Zealand

Study visits:

The treatment is given as a two-day infusion, twice over six months. Participants will be monitored for 12 months, at six clinic visits.

Participants will receive reimbursement for their travel.

Phone: +61 3 9231 2502

Email: [email protected]

---

Developing a digital tool to improve inpatient hospital diabetes care

Researchers from the Tasmanian Health Service and University of Tasmania are looking for people living with diabetes who’ve recently been admitted to hospital to take part in a study. The project aims to develop a digital tool that helps identify people with diabetes who may be at higher risk of health issues during their hospital stay.

Your participation involves a 60-minute online discussion led by a researcher, together with 3-7 other people with diabetes, or a one-on-one online interview with a researcher.

If you’re interested in taking part or have any questions, you can find more information at:

---

Share your views on using AI to help screen for diabetes-related kidney disease (DRKD)

Researchers at Deakin University are exploring how people living with type 2 diabetes feel about using AI to help screen for diabetes-related kidney disease (DRKD).

Adults (aged 18+) with type 2 diabetes are invited to take part in a 5-10 minute survey about how AI could be used to predict the future risk of diabetes-related kidney disease.

For more details, or to express your interest in taking part, please visit:

---

Understanding the relationship between chronic illness, social isolation, and loneliness for people aged 60 years or over

You are invited to take part in this research project if you have lived experience with chronic illness.

This study aims to understand the relationship between chronic illness, social isolation, and loneliness. You do not have to be experiencing loneliness or social isolation to participate. You will be asked to complete a short online screening survey to determine if the study is suitable for you. If you proceed, you will be asked to participate in a 30-45 minute online survey.

To be eligible to participate, you must:

• Be 60 years and over
• Be diagnosed with at least one of the nine common physical chronic diseases (i.e., arthritis, asthma, diabetes, back pain, cancer, chronic kidney disease, chronic obstructive pulmonary disease, osteoporosis, cardiovascular disease);
• Be able to read and write English (to the level of the daily newspaper);
• Reside in Australia;
• Not have a cognitive impairment (e.g., due to dementia or brain injury) or significant psychiatric comorbidity (e.g. psychosis, delirium).

You do not have to be experiencing loneliness or social isolation to participate.

Participant information and consent form:

For more details about the project, and to hear about the survey from the researchers themselves, visit the website:

Please refer to the study participant information and consent form for further information. Alternatively, if you would like to complete the survey by post, please email us at [email protected] and we can arrange this.

---

Understanding the experiences of young adults with chronic health conditions

Share your experience and help improve support services for others.

Researchers from Macquarie University are conducting an anonymous online survey to better understand the lived experiences, support needs, and treatment barriers faced by young adults living with chronic physical health conditions in Australia.

You may be eligible if you:

• Are 18 to 29 years old
• Have a chronic physical health condition (lasting 6+ months) that has been or is currently being managed by a healthcare professional
• Can read and write in English

After completing the full survey, you can enter a draw to win 1 of 4 $50 gift cards. Your participation is anonymous and completely voluntary.

Ready to take part? Visit:

For more information, contact: Nicole Harte (PhD Candidate) – [email protected]

Approved by MQ HREC (no. 520251942563583)

---

Navigating Movement: Understanding Physical Activity Experiences in Western Australians with Type 2 Diabetes and Lower Limb Complications

Cutain University is currently looking for people living with type 2 diabetes in Western Australia to share their experience in participating in physical activity programs.

We need your help to inform the development of physical activity recommendations for people living with type 2 diabetes and its related lower limb complications.

What does it involve? – Answering an online survey (10-15mins)

Benefit – You will enter a draw to win a grocery store voucher.

For more information and to consent to get involved visit:

If you have any questions about this study, please contact Dr Bingyan Pang via [email protected] or (08) 9266 4754.

Curtin University Human Research Ethics Committee (HREC) has approved this study (HRE2025-0515)

---

Clinical study of a potential new treatment for non-proliferative diabetic retinopathy (NPDR)

The SeeClear Study is looking to better understand a potential new treatment for non-proliferative diabetic retinopathy (NPDR). It is hoped that this investigational treatment can help reduce the symptoms of NDPR and may also stop disease progression. Your participation in the SeeClear Study may help to test how effective this treatment is and will help to gain more information about the safety and how well-tolerated this treatment is in patients with NPDR.

You or someone you care for may be able to take part if you/they:

• Are 18 years of age or older
• Have Type 1 Diabetes or Type 2 Diabetes
• Have non-proliferative diabetic retinopathy (NPDR)

To learn more about the SeeClear Study, please contact:

• Sydney Eye Hospital, 8 Macquarie St, Sydney NSW 2000; email: helen.jeong@sydney .edu.au
• University of the Sunshine Coast Clinical Trials, Level 1/9 Ochre Way, Sippy Downs QLD 4556; phone: 07 5409 8640
• Eye Clinic Albury Wodonga,1/669 Dean St, Albury NSW 2640; email: CByrne@ alburyeye.com.au
• Sydney Retina Clinic, 187 Macquarie St, Sydney NSW 2000; email: lchen@ sydneyretina.com.au
• Marsden Eye Specialists, 152 Marsden Street; Parramatta, NSW 2150; email: trish.forsyth@ marsdeneye.com
• Sydney West Retina, The Ashley Centre, Level 2, suite 34/1A Ashley Ln, Westmead NSW 2145; email: [email protected]
• Retina and Eye Consultants Level 3/33 Macmahon St, Hurstville NSW 2220; email: Julie.Coppock@ retinaandeye.com.au
• Royal Adelaide Hospital, Port Rd, Adelaide SA 5000; email: kylie.dansie@ sa.gov.au

---

Survey for health professionals working with children and adolescents (ages 5-17 years) with type 1 diabetes

ISPAD Jenious special interest group members would like to determine the barriers to participation of children and adolescents with type 1 diabetes in non-diabetes focused activities or programs.

We are looking for healthcare professionals with experience working with children and adolescents (ages 5-17 years) with type 1 diabetes attending a non-diabetes specific program or activity (in any country worldwide).

For further information, please visit the online survey:

---

Diabetic Macular Edema (DME) study

This study is evaluating the safety, tolerability, and effectiveness of a new investigation medication called avoralstat. In this clinical research study, avoralstat will be tested at different dose levels to understand how your body responds to and handles the study drug, and to see how you and your DME respond to an injection of avoralstat.

Avoralstat will be administered as a single ocular injection. Only one of your eyes will receive the injection.

While there are currently approved treatments for DME, they may not work for everyone and can have side effects. Avoralstat works differently than these existing treatments. It is injected into a specific area of the eye and is designed to release medication slowly over time. This could mean fewer injections and less frequent visits to the clinic, which may be more convenient for you.

If you choose to participate in the study, your involvement will last for approximately 6 months (24 weeks). During this time, you will have up to 9 visits at the study center and 1 remote visit or phone call. Our study centers are in Sydney, Melbourne, and Adelaide.

To acknowledge your time and effort, a flat-rate stipend will be provided per completed study visit to help offset expenses directly related to your participation, including transportation and meals.

Eligibility

You may be eligible for this study if you:

• Are between 18 and 65 years of age.
• Have been diagnosed with DME that requires treatment.
• Have well-controlled diabetes with a Glycated hemoglobin A1c (HbA1c) level < 10%.
• Have not received more than 3 anti-VEGF injections for DME.

All study-related medications, health assessments, and medical tests will be provided at no cost.

Before you decide whether to participate, we will provide you with all the necessary information about the study, including potential benefits and risks. You will have ample opportunity to ask questions and make an informed decision.

Your safety is our top priority. Throughout the study, you will be closely monitored by our medical team. If necessary, alternative treatments will be offered to ensure your well-being.

If you are interested in participating or would like further information, please email [email protected].

---

Cardiometabolic conditions – Epworth ENDCAM Study 

The is recruiting participants to participate in their ENDCAM research study. They are looking for people:

• 18 – 45 years old living in Australia
• are female or assigned female at birth
• are living with type 1 diabetes or type 2 diabetes, or other cardiometabolic condition
• have seen a doctor within the last 12 months

To participate, visit:

---

MT-101-101 trial for type 1 diabetes

The MT-101-101 study is a phase 1 clinical trial (first-time in humans). It will test the safety and dosing of a new treatment for autoimmune diseases, including type 1 diabetes. The trial treatment is designed to stop or reduce the immune attack on the pancreas that causes type 1 diabetes. Initial studies confirmed its safety in individuals without type 1 diabetes; it now needs to be tested in those with type 1 diabetes. The results of this study will assist researchers to determine the optimal dose for future treatments with this drug.

Who can get involved in Australia:

• People aged between 18 and 45 years
• Diagnosed with type 1 diabetes
• Currently using insulin (via injections or by pump)
• Living in Victoria

Treatment: People with type 1 diabetes will receive up to three doses of the trial medication through a vein in their arm at 29-day intervals. One dose will be a placebo (a dummy medication), and up to two doses will be the trial medication.

Study visits: The study will involve 15-18 visits to the clinic over 6 months. Participants will be compensated for travel expenses.

For more information visit: or complete the .

---

Consumer Advisory Group – Shaping a diabetic kidney disease risk test

Researchers are inviting people with lived experience to join a Consumer Advisory Group and help shape a new blood test that predicts the risk of chronic kidney disease (CKD). Your voice can help make a difference.

Researchers invite people living with type 2 diabetes to contribute their lived experience to shape a new predictive blood test, Promarker®D. Designed to identify people at risk of developing chronic kidney disease (CKD). We are looking for consumers to form a Consumer Advisory Group to work alongside the research team to help ensure the project is relevant, respectful, and meets the needs of people it is designed to help.

1-2 hour Meetings will be quarterly (online via Zoom) until mid-2026, with occasional adhoc meetings and emails in between. Flexible participation is supported.

An honorarium of $50.00 per hour (minimum 2 hours) is available for consumer involvement activities in line with CCI Program guidelines.

To find out more visit:

---

Manage your type 2 diabetes with antioxidant supplements

Australian Catholic University is recruiting participants for a study exploring whether a personalised antioxidant supplement regimen can help improve blood glucose control in people with type 2 diabetes.

By participating, you will contribute to important research that may lead to more tailored and effective strategies for supporting people living with type 2 diabetes.

Who can take part?

• Aged between 18 and 75 years
• Have a current HbA1c of 6% or higher
• Not currently using insulin therapy

Participants will be asked to take two antioxidant supplements (vitamin C and N-acetylcysteine) for three months and attend five 60-minute study visits at Australian Catholic University in Melbourne, scheduled according to your availability.

This study has approval from the ACU Human Research Ethics Committee (2024-3636HC).

For more information, please contact Sophie Broome ([email protected]) or click the link to read the participant information letter and find out if you are eligible:

---

Help improve food label knowledge

Researchers at CQUniversity are exploring ways to improve food label knowledge and use to help Australians with diabetes make informed food choices and manage blood sugar.

This study aims to understand the barriers and enablers in using food labels, with the goal of improving education and tools that support healthier food choices and diabetes management.

Who Can Take Part?

• Adults aged 18+ living in Australia
• Diagnosed with type 2 diabetes or prediabetes

that may take 20-30 minutes about your food label experience.

By completing the survey, you can enter the draw to win 1 of 20 x $50 gift vouchers.

---

Dietary quality, lifestyle, and health among Australian adults

The University of Newcastle & HMRI Food and Nutrition Research Program are looking for Australian adults to help researchers better understand the connection between your diet and your health by taking an online survey.

Participants are asked to take the online survey (open Australia wide) three times over 12 months. The survey takes approximately 40-60 minutes to complete on each of the three occasions.

All survey participants will go into the draw to win 1 of 5 $100 vouchers at each of the three time points.

Participants who complete the online survey and meet additional criteria may be eligible to complete in-person measures at the University of Newcastle (Callaghan campus) if they wish.

You are eligible to participate in the current study if you:

• Are currently living in Australia.
• Are an adult 18 years of age or over.

Please note that this study is not suitable for you if you are pregnant or breastfeeding.

For more information visit or reach out to the study team at [email protected].

Ethics approval number H-2023-0414.

---

Exploring Bodily Threat Monitoring as a Transdiagnostic Factor in Chronic Illness

Do you have cancer, diabetes, cardiovascular disease, or asthma? Researchers at the University of Sydney are looking for people with any of these health conditions to investigate perceptions of bodily threat in people experiencing chronic health conditions. This research could lead to improved and more targeted health interventions for people living with chronic health conditions.

This online study takes 30 minutes. Click the link below for more information and to complete the study!

---

T1D-Plus: Prevention of damage to insulin-producing cells

T1D-Plus will test different study treatments that aim to prevent damage to the body’s insulin-producing cells (known as beta cells) by the immune system. There is evidence to suggest that each study treatment might be helpful on its own. T1D-Plus will determine if being treated with more than one of the study treatments is more effective than just one.

Who can get involved in Australia currently:

• Aged between 18-44 years
• Type 1 diabetes diagnosed and commenced insulin therapy within the last 6 weeks
• People living in Victoria

Eligible participants will attend a randomisation visit, during which the study medication will be assigned, followed by 7 treatment visits and 3 phone visits, plus an optional clinic visit. The amount of time spent at the clinic at each visit may vary due to the differing tests and checks. Every participant in this trial will receive at least one study treatment. Participants will know which treatment(s) they receive.

To register your interest, ask questions, or receive a copy of the information and consent form, please register at or contact the ATIC team at [email protected].

---

T1D OBTAIN: Protection of insulin-producing cells in people recently diagnosed with type 1 diabetes

T1D OBTAIN is testing the safety and effectiveness of a new treatment designed to protect insulin-producing cells in people with recently diagnosed type 1 diabetes, who have commenced insulin therapy. The aim of the trial is to test whether the new treatment can protect the body’s own insulin production, help manage blood glucose levels, decrease doses of insulin, and if it is safe to take.

Who can get involved in Australia currently: 

• People aged between 18 and 35 years  
• Recently diagnosed with type 1 diabetes  
• Started insulin treatment in the past 90 days  
• Live in Victoria, New South Wales or Queensland 

Participants will be required to attend 10 trial visits to the clinical centre, over approximately 18 months. Participants will receive an injection of an active study drug or placebo once every two weeks for one year. The treatment is given either at the study site or by a nurse at home.

Participants will continue using insulin as part of their regular treatment.

To register your interest, ask questions, or receive a copy of the information and consent form, please register at or contact the ATIC team at [email protected].

---

The Wellbeing Equation: How Self-Care and Social Support Influence Subjective Wellbeing in Australians with Type 1 Diabetes

You are invited to participate in a study exploring the subjective wellbeing (i.e., quality of life) of Australian adults (aged 18+) diagnosed with type 1 diabetes.

We are seeking Australian adults, who have received a type 1 diabetes diagnosis by a medical professional to participate in an anonymous, online study.

Take part in our 15-minute survey to provide essential insights that can help shape future support services and resources for individuals with type 1 diabetes. All information is confidential and non-identifiable.

This research has been approved by my University’s Human Research Ethics Committee: Project number – 2025/072.

---

Do you have a child with type 1 diabetes?

Researchers at Griffith University and the University of Queensland are undertaking a study to investigate the experiences and needs of parents and siblings of children with type 1 diabetes in Australia.

Share your experiences and valuable thoughts by participating in an .

The survey aims to better understand factors that are linked to more positive outcomes for siblings of children with chronic health conditions in Australia, along with families’ needs and preferences for support. 

Enter a prize draw to win one of five $50 AUD gift vouchers.

For more information contact Kalpana Subasinghe at [email protected].

Ethics approval- Griffith University Ref No: 2024/339
GU Ref No: 2024/339

---

Type 2 diabetes and persistent pain

The University of Sydney is currently recruiting participants withÌýtype 2 diabetes and persistent painÌýfor a newÌýclinical trial. This trial will test a new online intervention developed to improveÌýpain severity and pain interference.Ìý

The study involves completing 4 x 10-15 minute online training sessions over two weeks, as well as some pre and post-intervention surveys. This study will take a maximum of 2.5 hours across a 3-month period. 

Your participation will help contribute to diabetes research, and we will donate $5 to ºÚÁÏÍø for each person who completes this study.  

To learn more and get involved, visit or email the research team at [email protected] 

---

Nerve health study for people with type 1 or type 2 diabetes

This study looks at how GLP-1 medications affect nerve health, using advanced non-invasive testing.

You may be eligible if:

• you have type 1 or type 2 diabetes
• you are starting or have already started GLP-1 medication, such as Ozempic, Trulicity, Mounjaro or Byetta
• you can attend 3 visits; baseline, 6 months and 12 months.

For more infomation:
Dr Indumathi Singh
[email protected]
0422 495 868

---

Manage your type 2 diabetes with expert clinical care

Join a six-month study to receive one-on-one support from ACU’s expert dietitians. Learn how your diet can positively impact your type 2 diabetes management, with professional guidance available to you anywhere across Australia.

Participants must be aged 18 years or over, have a confirmed type 2 diabetes diagnosis, a current HbA1c of at least 7.0% and not taking insulin.

Learn more at

---

Self-management support for type 2 diabetes: Global exploration of patients and health care professionals’ perspectives

A study is being conducted to explore the views and experiences of people living with type 2 diabetes and health care professionals (doctors, diabetes nurse-educator, general nurse, dietitians, psychologist, podiatrist and community health workers) over 18 to take part in a study that aims to understand the effectiveness of current diabetes management support strategies and identify barriers and facilitators to effective support mechanisms for diabetes self-management.

If you volunteer to participate, you will be provided with a link to complete a survey (15 minutes) and later invited for an interview if interested (30-45 minutes). Please note that participation in the interview is optional, and you may choose to have it conducted via Microsoft Teams rather than by phone.

Survey participants will receive $5 coffee voucher and all interview participants will go into a draw with 3 lucky winners receiving $50 Amazon online gift voucher.

Survey links

To find out more about the study, please contact Oluwatosin Arojojoye [email protected]

This study has received ethics approval from the James Cook University’s Human Research Ethics Committee (Approval number: H9661).

---

The Flash Study Evaluation

Seeking healthcare professionals to participate

This study aims to identify the barriers and enablers to the use of continuous glucose monitors by Aboriginal and Torres Strait Islander peoples with type 2 diabetes, and to determine pathways to overcome these barriers.

Participation involves one 45-minute semi-structured interview, which will be conducted in-person or online at your preferred time/day. We are seeking healthcare professionals experienced in providing care for Aboriginal and Torres Strait Islander peoples with type 2 diabetes who use continuous glucose monitors.

Please contact [email protected] for further information.

---

Wellbeing and type 1 diabetes

Seeking young people with type 1 diabetes

We understand that living with type 1 diabetes can impact a young person’s mental health due to the ongoing demands of management. In this program, we want to support you to develop helpful coping skills and boost your resilience. 

We are seeking young people aged 13-17 years who have been living with type 1 diabetes for at least 6 months to receive an online mental health and wellbeing program; designed by and for teens with type 1 diabetes.

For more information, or to complete the expression of interest, visit:

You can contact the team at The Kids Research Institute at [email protected] or on +61 493 702 900.

---

Diabetes prediction study

The PREDICTION study is looking for participants to help to understand more about diabetes and how to prevent diabetes complications.

To apply for this study, you must:

• have type 1 or type 2 diabetes
• have been diagnosed after 2016
• have been between 15 and 40 when diagnosed.

Study participants can do most of what is required for the study from the comfort of their own home.

Once selected for the study, you will be asked to attend a local private pathology clinic (at our cost) to get your blood and urine samples collected, and get your blood pressure measured at your local pharmacy.

If you are interested in participating or would like further information, visit .

You can contact the study team on (03) 8532 1826 or email [email protected].

---

Help improve preventive health care for people with intellectual disability

This study wants to make health action planning better for people with intellectual disability.

What is this study about?

People with intellectual disability can have poor health. This project wants to make it easy for people with intellectual disability to engage in health action planning with their doctor to take care of their
preventive health. (e.g., dietary changes, specialist referrals, screening procedures, blood tests).

Through our partnership with key groups, this study will communicate with people with intellectual disability, their support networks (paid and non-paid) and health professionals to improve health action planning for people with intellectual disability. We want to learn from the experiences of health care professionals who have provided preventive health care to people with intellectual disability.

What will happen if you take part

We will ask to you come to an interview or group meeting (called a focus group). We will ask you questions in person, online or on the phone to learn about your experiences. We can communicate with you in a different way if you prefer. The meeting will take about 1 to 2 hours.

You will receive a $50 gift card for your participation.

Your experiences will be used to help us improve preventive health care for people with intellectual disability.

If you have questions, or want to join the study, contact Jack Cooper at [email protected] or on +61 434 182 259.

---

Paratus Clinical – type 2 diabetes and weight loss

This clinical trial looks to investigate type 2 diabetes and weight loss. Learn more at

If you have difficulty managing your type 2 diabetes whilst on Metformin, and have not had any weight loss medications recently, you might be eligible for a new clinical trial.

Eligible participants will visit the clinic up to 12 times with an additional 8 phone visits over approximately 16 months (69 weeks).  Once enrolled in the clinical trial, participants will be randomly allocated to receive either the study medicine or Tirzepatide, the comparator. All treatments will be administered by an injection into a fold of skin on the stomach, thigh or upper arm once weekly.

This clinical trial is sponsored by Novo Nordisk.

---

Dietary quality, lifestyle and health among Australian adults

This project aims to explore the relationships between dietary habits and other health related factors such as demographic and mental health.

You are eligible if you are 18 years or over and live in Australia. This study is not for you if you are pregnant or breastfeeding.

Phase 1 – an online survey that takes approximately 40 – 60 minutes to compete on each of the three occasions over 12 months.

Phase 2 (optional) – one off in-person assessment at the University of Newcastle (Callaghan campus).

All phase 1 participants completing both surveys will be entered into the draw to win one of five $100 gift vouchers at each of the three occasions.

To complete the online survey visit:

Reach out to the study team at [email protected]

---

Study: A clinical research study for people with excess weight and heart disease

TRIUMPH-Outcomes is a clinical research study for people with excess weight who
also have heart disease or kidney disease, or both.

You may be able to join this research study if you:

• have a BMI of 27 kg/m2 or more
• are aged 45 years or older
• have at least one of the following:
  â—‹ heart disease
  â—‹ kidney disease
  â—‹ type 2 diabetes or not, and your HbA1c levels are equal to or less than 10 percent (86 mmol/mol).

TRIUMPH-3 is a clinical research study for people with excess weight and heart disease.
The study will test how safe and well the investigational medicine (the medicine being
studied) works for weight management.

You may be able to join the research study if you:

• Are aged 18 years or older
• Have obesity, with a BMI of 35 or higher
• Have heart disease
• Have not been able to lose body weight on your own.

For more information contact Northern Beaches Clinical Research on:
Ph: 1300 55 96 76
Email: [email protected]

---

Study: Understanding the experience of diabetic peripheral neuropathy and potential
treatment to improve the sense of touch.

Medical professionals with extensive experience and knowledge of treating individuals with diabetic
peripheral neuropathy wanted for an interview study investigating the needs and experiences of those living with peripheral neuropathy and to document your opinions of a conceptual device to improve the sense of touch. The study can provide insights to inform the development of new treatments or technologies using a patient-centred approach that facilitates patient engagement and empowers the voices of those with real lived experience.

Eligibility requirements:

• Medical professionals who have extensive experience and knowledge of treating individuals with
  diabetic peripheral neuropathy.
• Five years or more working directly with patients with diabetic peripheral neuropathy.
• Be willing to speak in depth with researchers about your experience of working with individuals
  with diabetic peripheral neuropathy.
• Be willing to provide your opinion of a conceptual device to improve the sense of touch.

Duration: 1 hour

You will receive a $30 e-voucher per hour for participation.

Where: Western Sydney University (Westmead Campus) or remotely via Zoom.

All aspects of the study are confidential. You will not be identified from any data collected. Results of the experiment will be reported in journal articles and conference papers, but no individual data will be presented.

Your participation in this study is voluntary. You may withdraw from the study at any time; you do not need to give a reason and there will be no consequences for doing so.

This project has Western Sydney University HREC ethics approval MA03199.

To participate scan the QR code below or email Prof. Paul Breen for more information.

Email: [email protected]

To complete the survey visit:

---

Study: Understanding the experience of diabetic peripheral neuropathy and potential treatment to
improve the sense of touch.

Adults with diabetic peripheral neuropathy wanted for an interview study investigating the experiences of living with peripheral neuropathy and to document your opinions of a conceptual device to improve the sense of touch. The study can provide insights to inform the development of new treatments or technologies using a patient-centred approach that facilitates patient engagement and empowers the voices of those with real lived experience.

Eligibility requirements:

• Have peripheral neuropathy (numbness/loss of feeling in hands and feet) as a result of diabetes mellitus.
• Be an adult over the age of 18.
• Be willing to provide your opinions of a conceptual device to improve the sense of touch.
• Be willing to speak in depth with researchers about your experiences of diabetic peripheral neuropathy.

Exclusion criteria:

• If you have history of severe psychiatric disorder.
• If you have neuropathy due to other causes, including, but not limited to, autoimmune disorders, inflammatory neuropathies (including acute or chronic inflammatory demyelinating polyneuropathy), thyroid disease or endocrine disorders other than diabetes, heavy metal or chemical-agent exposures, nutritional deficiency, metabolic disorders, vasculitis, heredity, infections, injury, or paraneoplastic syndromes.
• If you have previously had any amputation.
• Current active diabetic foot uclers.
• Not ambulatory (participants who used a cane or walkers were allowed).

Duration: 1 hour

You will receive a $30 e-voucher per hour for participation.

Where: Western Sydney University (Westmead Campus) or remotely via Zoom.

All aspects of the study are confidential. You will not be identified from any data collected. Results of the experiment will be reported in journal articles and conference papers, but no individual data will be presented.

Your participation in this study is voluntary. You may withdraw from the study at any time; you do not need to give a reason and there will be no consequences for doing so.

To participate in the study visit the study survey:

Or for more information email Prof. Paul Breen: [email protected]

This project has Western Sydney University HREC ethics approval MA03199.

---

What does diabetes support look like to you?

Co-design of a digital health intervention for people with type 2 diabetes in the Australian setting 

RMIT University, Monash University and Parkside Specialists.  

We want to understand your views on a healthy lifestyle behaviour program for managing type 2 diabetes.  

If you fit the following criteria, take our short anonymous survey and tell us what diabetes support means to you. 

• Adults aged 18+ 
• Australian resident 
• Diagnosed with type 2 diabetes 
• Or carer/family member of people living with type 2 diabetes 

Potential benefits:

• A chance to win 1 of 5 Gro Health mobile application membership to help be your best you 
• By sharing your experiences, insights, and perspectives, you can help improve and develop more effective, patient-centered healthcare interventions and programs. 

The survey may take 10 minutes and requires you to access it via this link:

---

Bone-muscle interaction in patients with type 2 diabetes & the effects of exercise

Victoria University and Australian Institute for Musculoskeletal Science

Do you have type 2 diabetes?

Seeking male and female volunteers over the age of 18 with type 2 diabetes to participate in a study examining the effects of exercise on bone-muscle-fat interaction and its relationship to health and function.

What’s involved?

Participants will be randomised to exercise training (cycling) or control (usual activities).

Assessments include:

•  Aerobic fitness and strength Blood and urine samples
•  Mobility Glucose tolerance testing
•  Questionnaires Fat and muscle samples (optional)
•  Bone and muscle scans

Where is it?

Victoria University, Footscray Park

What’s in it for me?

Reimbursement. You may receive gift cards up to $100 value.

Some participant exclusions may include:

•  Warfarin or Vit K medications
•  Current smoker or quit in the past 12 months
•  BMI over 40

To see if you can get involved, contact:

Email Rhiannon Healy: [email protected]

---

Understanding mobile health intervention needs of Australians living with type 2 diabetes

University of Southern Queensland

Are you interested in participating in a study to identify the key features of mobile health apps to improve self-management of type 2 diabetes? 

Are You  

• Over 18 years old  
• Living with type 2 diabetes  
• Able to complete a survey online  
• English speaking  
• Smart phone/mobile device user.  

Potential Benefits  

Participating in this study will help us to identify and understand the advanced features needed in a mobile health app to improve self-management of Type 2 Diabetes. 

Participation involves completing an online survey that takes 15 – 30 minutes.

---

Developing a model of preventive health care for people with intellectual disability

We are doing a research study on having good health. We want to hear from people with intellectual disability, their support networks and health professionals.

If you are interested:

Contact: Bela Laginha

Email: [email protected]

Phone: +61 2 9348 0190

HREC Approval Number: HC220517 – August 2022

---

Cardiovascular study for women

Are you female, aged 40 – 65 years, and want to reduce your risk of heart disease?

And you have had a history of:

• Diabetes during pregnancy (gestational diabetes) or
• High blood pressure or pre-eclampsia during pregnancy or
• Early menopause (under the age of 44 years) or
• Are of Aboriginal / Torres Strait Islander background (aged 35 – 65 years).

You could be eligible for the CAC-Women’s Trial.

This is a large national study of 6 months duration with all women receiving a free specialised CT scan of the heart arteries.

To find out more, submit your enquiry by sending your email address and mobile phone number to: [email protected]

This research project has been approved by the Western Sydney Local Human Research Ethics Committee – dated 22 April 2022.

---

The MothersBabies Study

Are you interested in groundbreaking pre-pregnancy research?

UNSW’s Microbiome Research Centre is looking at the impact of gestational diabetes in previous pregnancies, as well as how your pre-pregnancy lifestyle (diet, exercise, medications, pre-existing medical conditions) could affect your microbiome.

How do I get involved?

If you’d like to sign up, or see if you are eligible, fill out the form available at . If you’d like to chat more information or to a researcher, please email [email protected].

Research Approvals

HREC Approval: 2019/ETH00192

ANZCTR Number: ACTRN12619000800123

Australian Breastfeeding Association Research Approval: 2020-4

---

A new, investigational procedure to help manage blood glucose levels in individuals living with type 2 diabetes

Are you looking for a new way to help manage your Type 2 Diabetes?

The REGENT-1 clinical study is evaluating a new, non-surgical, endoscopic treatment (called the Endogenex procedure) that may interest you.

During an Endogenex procedure, a small flexible camera (endoscope) is used to guide a special device through the mouth and past the stomach into the first portion of the small intestine called the duodenum. This device applies therapy to the surface of the duodenum which initiates the regeneration or regrowth of healthy cells that help the body manage blood glucose levels.

Because the Endogenex procedure is done endoscopically, this means there will be no incisions (cuts or scars). Patients will go home the same day and normal physical activity can usually be resumed the next day.

You may be eligible to be included in the study if you:

• Are between 18 and 70 years of age
• Have been diagnosed with type 2 diabetes
• Have a BMI of 24-40 kg/m²
• Have HbA1C of 7.5-11.0%
• Are taking medication to help manage blood glucose levels
• Do not take any steroids, blood-thinners, anti-coagulation medications (eg. warfarin), weight loss medications, or non-steroidal anti-inflammatory drugs that cannot be stopped for one month
• Have not had any previous gastrointestinal surgery that has changed your anatomy (eg. gastric bypass, gastric band or gastric sleeve surgery)
• Do not have any autoimmune disease (excluding Graves’ or Hashimoto’s disease, with adequately replaced thyroid hormones)
• Do not suffer from irritable bowel syndrome (IBS) or inflammatory bowel disease (eg. Crohn’s disease, coeliac)
• Do not consume excessive alcohol
• No pregnant or plan to be pregnant in next year
• Meet all eligibility criteria as assessed by your study doctor

Please visit for more information.

---

‘Stepping up’ exercise for type 2 diabetes: A stepped care approach to lifestyle therapy

This research project aims to examine the effects of an adaptive exercise approach to improving health for individuals with Type 2 Diabetes. We are specifically examining the effect of adapting an exercise program on blood glucose management, abdominal fat, and cardiorespiratory health.

• Are you between 25-69 years of age?
• Have you been diagnosed with Type 2 Diabetes?
• Do you have a waist circumference >80cm (women) or >94cm (men)?
• Are you willing to complete regular supervised and/or unsupervised exercise sessions?
• Are you willing to participate in assessments of physical health and lifestyle behaviours?
• Are you willing to wear a wrist-based activity tracker for the duration of the study?

For this trial, you will be randomized (like the toss of a coin) into one of two groups. The first group will be required to complete a minimum of 150 minutes of exercise, which includes a home exercise program. The second group will receive exercise and nutritional advice. At regular time-points, you will be required to attend health assessments to assess your response to the intervention at the Charles Perkins Centre (Camperdown). Your exercise program may be adjusted throughout trial depending on your assessment results. The duration of your trial participation will vary (8 months minimum, 12 months maximum).

This study is being conducted at the University of Sydney Charles Perkins Centre (John Hopkins Dr, Camperdown, NSW, 2006) in conjunction with the University of Queensland.

This study has been approved by the NSW Sydney Local Health District (Royal Prince Alfred Hospital Zone).

Ethics approval number: X21-0016.

For any questions, or to express interest in participating, please contact:

Alex Armstrong ([email protected])

---

Type1Screen – Australia’s National Screening Program for family members

Type1Screen is an Australian initiative offering free type 1 diabetes risk screening.

The aim of Type1Screen is to identify people at risk of developing type 1 diabetes as early in the disease process as possible before symptoms develop. To be eligible for Type1Screen, individuals must be aged over 2 years and have a family history of type 1 diabetes.

How do I get involved?

Participation involves a blood test either at a local pathology collection centre or via a test which can be sent to, and done in, the home. Registration is available directly online. .

The blood sample goes to a lab in Melbourne and results are sent back within 8 weeks of sample receipt.

Those who are found to be antibody-positive will be supported through a national network of diabetes centres and offered further testing to determine their risk of developing diabetes. They will also be offered the opportunity to enter any available prevention studies through the .

Further information about Type1Screen is available at the or by following their or Instagram pages @type1screen. For further information email the team at [email protected].

---

Do you have Type 2 diabetes and foot nerve damage?

People with Type 2 Diabetes may develop foot nerve damage (peripheral neuropathy), as a complication. Symptoms might include: numbness of the feet; coldness in the legs; tingling or pins and needles in the feet; burning pain in the feet and legs. Peripheral neuropathy can affect balance and walking, and increase the risk of falling. Researchers at The University of Queensland are seeking participants for a trial of different shoe insoles which may improve balance, walking and foot sensation in adults with Type 2 diabetes and peripheral neuropathy.

I’m interested, what would be involved?

You would be given a pair of shoe insoles to wear for 4 weeks. Across 2 sessions we will measure the feeling in your feet, standing balance, and walking ability whilst barefoot, wearing shoes, and 2 different insoles (textured and smooth). You will be required to wear a small wireless activity monitor for 2 weeks, and complete 3 short surveys relating to your general health, diabetes, foot health, falls, and experience wearing the insoles.

Am I eligible to take part?

To be eligible to participate in this trial you MUST: – be aged 18 years or older – have Type 2 diabetes and peripheral neuropathy – live in South East Queensland – be able to walk over 20 metres with/without an aid (e.g. walking stick) – be willing to wear shoe insoles for 4 weeks

There are some medical conditions that would make you ineligible to take part. Please contact the lead researcher, Dr Anna Hatton, to find out more (see below).

What will I receive for taking part?

Participants will be remunerated for their transport to and from The University of Queensland (St Lucia campus) for assessments, by way of return taxi fares (within the Brisbane region) or day car parking.

To register your interest to take part, please follow the survey link below:

I would like to know more: Please contact Dr Anna Hatton on: (Tel) 07 3365 4590 or (Email) [email protected]

---

Clinical Trials Connect

Clinical Trials Connect (CTC) was established in 2008. CTC is an online participant recruitment website designed to help match members of the Australian community to research opportunities Australia wide, and deliver recruitment solutions to researchers.

People can register their interest to participate in trials on the website either as a healthy volunteer or as a patient with an existing medical condition.